Immunohistochemical expression and significance of SATB2 protein in colorectal cancer

被引:10
作者
Cigerova, Veronika [1 ]
Adamkov, Marian [1 ]
Drahosova, Slavka [2 ]
Grendar, Marian [3 ]
机构
[1] Comenius Univ, Jessenius Fac Med Martin, Dept Histol & Embryol, Mala Hora 4, Martin 03601, Slovakia
[2] Hermes LabSyst Sro, Puchovska 12, Bratislava 83106, Slovakia
[3] Comenius Univ, Jessenius Fac Med Martin, Biomed Ctr Martin, Dept Bioinformat, Mala Hora 4C-4D, Martin 03601, Slovakia
关键词
SATB2; Colorectal cancer; Microsatellite instability; Inflammation; Hypoxia; HYPOXIA-INDUCIBLE FACTORS; MICROSATELLITE-INSTABILITY; CARCINOMA; MARKER; CYCLOOXYGENASE-2; ADENOCARCINOMA; PROGRESSION; METASTASIS; INTERACTS; CELLS;
D O I
10.1016/j.anndiagpath.2021.151731
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In this study we evaluated the expression of SATB2 protein in colorectal cancer (CRC) and its association with microsatellite instability (MSI) status, inflammation and hypoxia. Immunohistochemical SATB2 expression was observed in 111 CRC samples. We assessed the correlation between SATB2 expression and clinico-morphological parameters, MSI, COX-2 and HIF-1 alpha expression. SATB2 was noticed in 92.8% CRC. We observed nuclear staining with predominantly strong immunoreaction intensity (67.6%) and percentage of SATB-2 positive cells in more than 50% of cells (87.4%). The statistically significant associations were recorded between high SATB2 expression and low grade, negative lymph nodes and negative vascular invasion. Statistical analysis confirmed a significant correlation between SATB2 expression and microsatellite stability, tendency to correlate with COX-2 and no significant correlation with HIF-1 alpha. SATB2 is overexpressed in CRC and its high expression is a marker of good prognosis. Moreover, SATB2 expression is significantly associated with microsatellite stability, there is tendency to correlate with proinflammatory COX-2 and there is no association with hypoxia.
引用
收藏
页数:6
相关论文
共 37 条
[1]   Relationship of mismatch repair proteins and survivin in colon polyps and carcinomas [J].
Adamkov, Marian ;
Furjelova, Martina ;
Horacek, Jaroslav ;
Bencat, Marian ;
Kruzliak, Peter .
ACTA HISTOCHEMICA, 2014, 116 (06) :1007-1014
[2]   Global patterns and trends in colorectal cancer incidence and mortality [J].
Arnold, Melina ;
Sierra, Monica S. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
GUT, 2017, 66 (04) :683-691
[3]   SATB2 as an Immunohistochemical Marker for Colorectal Adenocarcinoma A Concise Review of Benefits and Pitfalls [J].
Berg, Kyra B. ;
Schaeffer, David F. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (10) :1428-1433
[4]  
Bosman F. T., 2010, WHO classification of tumours of the digestive system
[5]   Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS [J].
Britanova, O ;
Akopov, S ;
Lukyanov, S ;
Gruss, P ;
Tarabykin, V .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (03) :658-668
[6]   SATB1 and 2 in colorectal cancer [J].
Brocato, Jason ;
Costa, Max .
CARCINOGENESIS, 2015, 36 (02) :186-191
[7]   Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis [J].
Chen, Yuhan ;
Li, Xianming ;
Wu, Shihai ;
Xu, Gang ;
Zhou, Yayan ;
Gong, Long ;
Li, Zihuang ;
Yang, Dong .
MEDICAL ONCOLOGY, 2014, 31 (12) :1-7
[8]   The loss of SATB2 promotes ulcerative colitis-related colon cancer progression through altered localized inflammatory response [J].
Das, Sudipto ;
Naicker, Kirsha ;
Klinger, Rut ;
Fan, Yue ;
Mallya, Girish ;
Ponten, Fredrick ;
Jirstrom, Karin ;
O'Sullivan, Jacintha ;
Gallagher, William M. ;
Brenan, Donal J. ;
O'Connor, Darran P. .
CANCER RESEARCH, 2018, 78 (13)
[9]   The Role of SATB2 as a Diagnostic Marker for Tumors of Colorectal Origin [J].
Dragomir, Anca ;
de Wit, Meike ;
Johansson, Christine ;
Uhlen, Mathias ;
Ponten, Fredrik .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (05) :630-638
[10]   A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer [J].
Eberhard, J. ;
Gaber, A. ;
Wangefjord, S. ;
Nodin, B. ;
Uhlen, M. ;
Lindquist, K. Ericson ;
Jirstrom, K. .
BRITISH JOURNAL OF CANCER, 2012, 106 (05) :931-938